Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -2.38% | -8.21% | +21.78% |
05-15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.78% | 77.67M | |
+10.27% | 115B | |
+11.97% | 106B | |
-5.84% | 24.69B | |
-1.19% | 21.97B | |
-4.83% | 19.27B | |
-11.82% | 17.56B | |
-39.36% | 17.32B | |
+5.68% | 14.03B | |
+33.15% | 12.13B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Chardan Adjusts Price Target on Passage Bio to $43 From $45, Maintains Buy Rating